FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis

Filippo Pietrantonio, Giovanni Fucà, Daniele Rossini, Hans Joachim Schmoll, Johanna C. Bendell, Federica Morano, Carlotta Antoniotti, Salvatore Corallo, Beatrice Borelli, Alessandra Raimondi, Federica Marmorino, Monica Niger, Alessandra Boccaccino, Gianluca Masi, Sara Lonardi, Luca Boni, Filippo de Braud, Maria Di Bartolomeo, Alfredo Falcone, Chiara Cremolini

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences